Share
Other content recommended for you
- Public healthcare resource allocation and the Rule of Rescue
- Donor blood screening and moral responsibility: how safe should blood be?
- The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process
- Should rare diseases get special treatment?
- NICE is dead; long live NICE
- A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors
- All health is not equal: the use of modifiers in NICE technology appraisal
- Wickedness or folly? The ethics of NICE’s decisions
- Justice and the NICE approach
- Value assessment frameworks: who is valuing the care in healthcare?